-
Cost of pharmacotherapy for opioid use disorders following inpatient detoxification.
McCollister KE, Leff JA, Yang X, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR, Murphy SM. Cost of pharmacotherapy for opioid use disorders following inpatient detoxification. American Journal of Managed Care 2018;24(11):522-527
-
Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data.
Wu L, Zhu H, Ghitza UE. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data. Drug and Alcohol Dependence 2018;192:316-323.
-
Brief report: Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial.
Campbell ANC, Barbosa-Leiker C, Hatch-Maillette M, Mennenga SE, Pavlicova M, Scodes J, Saraiya T, Mitchell SG, Rotrosen J, Novo P, Nunes EV, Greenfield SF. Brief report: Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial. American Journal on Addictions 2018;27(6):465-470.
-
Correlates of long-term opioid abstinence after randomization to methadone versus buprenorphine/naloxone in multi-site trial.
Zhu Y, Evans EA, Mooney LJ, Saxon AJ, Kelleghan A, Yoo C, Hser Y. Correlates of long-term opioid abstinence after randomization to methadone versus buprenorphine/naloxone in multi-site trial. Journal of Neuroimmune Pharmacology 2018;13(4):488-497.
-
Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network Study.
McClure EA, Baker NL, Sonne SC, Ghitza UE, Tomko RL, Montgomery L, Babalonis S, Terry GE, Gray KM. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network Study. Drug Alcohol Depend 2018;192:59-66.
-
Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment.
Shulman M, Campbell ANC, Pavlicova M, Hu M, Aharonovich E, Nunes EV. Cognitive Functioning and Treatment Outcomes in a Randomized Controlled Trial of Internet-Delivered Drug and Alcohol Treatment. American Journal on Addictions 2018;27(6):509-515.
-
A complier average causal effect analysis of the STimulant Reduction Intervention using Dosed Exercise study.
Carmody T, Greer TL, Walker R, Rethorst CD, Trivedi MH. A complier average causal effect analysis of the STimulant Reduction Intervention using Dosed Exercise study. Contemporary Clinical Trials Communications 2018;10:1-8.
-
Menthol cigarette smoking among individuals in treatment for substance use disorders.
Gubner NR, Williams DD, Pagano A, Campbell BK, Guydish JR. Menthol cigarette smoking among individuals in treatment for substance use disorders. Addictive Behaviors 2018;80:135-141.
-
Cigarette smoking and quit attempts among Latinos in substance use disorder treatment.
Pagano A, Gubner N, Le T, Guydish JR. Cigarette smoking and quit attempts among Latinos in substance use disorder treatment. American Journal of Drug and Alcohol Abuse 2018;44(6):660-667.
-
Generalizability of the findings from a randomized controlled trial of a web-based substance use disorder intervention.
Susukida R, Crum RM, Stuart EA, Mojtabai R. Generalizability of the findings from a randomized controlled trial of a web-based substance use disorder intervention. American Journal on Addictions 2018;27(3):231-237.